Donald E. Mager

7.2k total citations
167 papers, 5.5k citations indexed

About

Donald E. Mager is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Donald E. Mager has authored 167 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 46 papers in Oncology and 31 papers in Hematology. Recurrent topics in Donald E. Mager's work include Pharmacogenetics and Drug Metabolism (22 papers), Computational Drug Discovery Methods (22 papers) and Receptor Mechanisms and Signaling (21 papers). Donald E. Mager is often cited by papers focused on Pharmacogenetics and Drug Metabolism (22 papers), Computational Drug Discovery Methods (22 papers) and Receptor Mechanisms and Signaling (21 papers). Donald E. Mager collaborates with scholars based in United States, France and United Kingdom. Donald E. Mager's co-authors include William J. Jusko, William J. Jusko, Robert M. Straubinger, Wojciech Krzyżański, Leonid Kagan, Nicholas M. P. King, Elżbieta Wyska, Jin Niu, Sihem Ait‐Oudhia and John M. Harrold and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Diabetes Care.

In The Last Decade

Donald E. Mager

163 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald E. Mager United States 39 2.1k 1.1k 904 642 553 167 5.5k
Alberto Corsini Italy 54 3.0k 1.4× 829 0.8× 264 0.3× 1.3k 2.0× 517 0.9× 294 10.5k
Thomayant Prueksaritanont United States 37 1.6k 0.8× 1.7k 1.6× 805 0.9× 353 0.5× 1.6k 2.8× 124 5.2k
Gillian Smith United Kingdom 44 2.1k 1.0× 1.5k 1.4× 1.1k 1.3× 327 0.5× 1.1k 1.9× 127 7.1k
Simon D Harding United Kingdom 24 2.9k 1.4× 628 0.6× 194 0.2× 701 1.1× 411 0.7× 36 6.9k
Juan Tamargo Spain 56 4.3k 2.1× 882 0.8× 1.1k 1.2× 356 0.6× 367 0.7× 364 15.8k
Noriaki Shimada Japan 57 1.8k 0.9× 1.4k 1.3× 2.7k 3.0× 332 0.5× 2.4k 4.4× 207 9.6k
Jean‐Sébastien Hulot France 54 1.8k 0.9× 900 0.9× 336 0.4× 307 0.5× 1.1k 2.0× 218 10.7k
Liewei Wang United States 48 4.7k 2.3× 2.0k 1.9× 202 0.2× 655 1.0× 958 1.7× 233 8.7k
Uwe Christians United States 51 2.3k 1.1× 1.6k 1.5× 186 0.2× 609 0.9× 1.2k 2.2× 360 10.9k
Rodolfo Paoletti Italy 43 2.2k 1.1× 525 0.5× 279 0.3× 827 1.3× 324 0.6× 132 8.7k

Countries citing papers authored by Donald E. Mager

Since Specialization
Citations

This map shows the geographic impact of Donald E. Mager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald E. Mager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald E. Mager more than expected).

Fields of papers citing papers by Donald E. Mager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald E. Mager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald E. Mager. The network helps show where Donald E. Mager may publish in the future.

Co-authorship network of co-authors of Donald E. Mager

This figure shows the co-authorship network connecting the top 25 collaborators of Donald E. Mager. A scholar is included among the top collaborators of Donald E. Mager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald E. Mager. Donald E. Mager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rostami‐Hodjegan, Amin, et al.. (2025). Mathematical Modeling of Neuroinflammation in Neurodegenerative Diseases. CPT Pharmacometrics & Systems Pharmacology. 14(12). 1908–1922.
2.
Li, Cheryl, Scott Van Wart, Lili Yang, et al.. (2025). Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling of Serum M‐Protein Response for Modakafusp Alfa in a Phase 1/2 Study of Patients With Relapsed or Refractory Multiple Myeloma. Clinical and Translational Science. 18(7). e70296–e70296. 1 indexed citations
3.
Mager, Donald E.. (2025). Breadth of Pharmacology Modeling: Fundamentals of Pharmacokinetics, Pharmacodynamics, and Mechanistic Modeling. Handbook of experimental pharmacology. 289. 21–73. 1 indexed citations
4.
McCune, Jeannine S., Saro H. Armenian, Ryotaro Nakamura, et al.. (2023). Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients. Journal of Oncology Pharmacy Practice. 30(2). 322–331.
5.
6.
Fouliard, Sylvain, Ibtissam Marchiq, Sandra Dupouy, et al.. (2022). Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia. Cancer Research Communications. 2(11). 1532–1544. 14 indexed citations
7.
Davenport, Patricia, Henry A. Feldman, Viola Lorenz, et al.. (2022). Platelet transfusions in a murine model of neonatal polymicrobial sepsis: Divergent effects on inflammation and mortality. Transfusion. 62(6). 1177–1187. 12 indexed citations
8.
Jusko, William J., et al.. (2021). Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation. Journal of Pharmacology and Experimental Therapeutics. 377(3). 370–384. 5 indexed citations
9.
Zhang, Li & Donald E. Mager. (2020). Population-based meta-analysis of bortezomib exposure–response relationships in multiple myeloma patients. Journal of Pharmacokinetics and Pharmacodynamics. 47(1). 77–90. 5 indexed citations
10.
Campagne, Olivia, Sylvain Fouliard, Marylore Chenel, et al.. (2018). Integrated Pharmacokinetic/Pharmacodynamic Model of a Bispecific CD3xCD123 DART Molecule in Nonhuman Primates: Evaluation of Activity and Impact of Immunogenicity. Clinical Cancer Research. 24(11). 2631–2641. 41 indexed citations
11.
12.
Cirincione, Brenda, et al.. (2016). Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration. The AAPS Journal. 19(2). 487–496. 16 indexed citations
13.
Ait‐Oudhia, Sihem, Meric Ovacik, & Donald E. Mager. (2016). Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicity. mAbs. 9(1). 15–28. 5 indexed citations
14.
Mager, Donald E., et al.. (2013). Population Pharmacokinetics and Dose Optimization of Mycophenolic Acid in HCT Recipients Receiving Oral Mycophenolate Mofetil. The Journal of Clinical Pharmacology. 53(4). 393–402. 36 indexed citations
15.
Harrold, John M., Robert M. Straubinger, & Donald E. Mager. (2012). Combinatorial Chemotherapeutic Efficacy in Non-Hodgkin Lymphoma Can Be Predicted by a Signaling Model of CD20 Pharmacodynamics. Cancer Research. 72(7). 1632–1641. 25 indexed citations
16.
Ait‐Oudhia, Sihem, Robert M. Straubinger, & Donald E. Mager. (2012). Meta-analysis of Nanoparticulate Paclitaxel Delivery System Pharmacokinetics and Model Prediction of Associated Neutropenia. Pharmaceutical Research. 29(10). 2833–2844. 20 indexed citations
17.
Kagan, Leonid, Pavel Gershkovich, Kishor M. Wasan, & Donald E. Mager. (2011). Physiologically Based Pharmacokinetic Model of Amphotericin B Disposition in Rats Following Administration of Deoxycholate Formulation (Fungizone®): Pooled Analysis of Published Data. The AAPS Journal. 13(2). 255–64. 25 indexed citations
18.
Agostini, Joseph V., Sarah N. Hilmer, Ronald I. Shorr, et al.. (2007). a drug burden index to define the functional burden of medications in older people. Commentary : A step forward. JAMA Internal Medicine. 167(8). 1 indexed citations
19.
Mager, Donald E., et al.. (2007). Analysis of Functional Signaling Domains from Fluorescence Imaging and the Two-Dimensional Continuous Wavelet Transform. Biophysical Journal. 93(8). 2900–2910. 10 indexed citations
20.
Mager, Donald E., Mary Ann Mascelli, Neal S. Kleiman, Desmond J. Fitzgerald, & Nicholas M. P. King. (2003). Simultaneous Modeling of Abciximab Plasma Concentrations and ex Vivo Pharmacodynamics in Patients Undergoing Coronary Angioplasty. Journal of Pharmacology and Experimental Therapeutics. 307(3). 969–976. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Corsini Breakdown of academic impact, for papers by Thomayant Prueksaritanont Breakdown of academic impact, for papers by Gillian Smith Breakdown of academic impact, for papers by Simon D Harding Breakdown of academic impact, for papers by Juan Tamargo Breakdown of academic impact, for papers by Noriaki Shimada Breakdown of academic impact, for papers by Jean‐Sébastien Hulot Breakdown of academic impact, for papers by Liewei Wang Breakdown of academic impact, for papers by Uwe Christians Breakdown of academic impact, for papers by Rodolfo Paoletti
Rankless by CCL
2026